Login
← Go Back
Syncom Formulations India
SYNCOMF · Pharma > Pharmaceuticals & Drugs
Stock Price vs Company Growth
1d
3.5%
1w
4.1%
1m
11.1%
3m
3.5%
6m
17.6%
1y
41.1%
5y
72.7%
10y
15.0%
all
16.2%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowSep15Dec17Sep19Jun21Mar23Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 17.4 3.5%
14.1
19.4
Company Overview
Sales
392 Cr
Growth: 33.1%
Profit after Tax
39.1 Cr
Growth: 18.1%
Small Cap
1,631 Cr
P/E: 34.0x
Industry P/E: 29.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 392
Growth 33.1%
EBITDA 11.9%
P/S 4.2x
Dividend 0.0%
P/E 34.0x
Book Value ₹ 3.4
PEG Ratio 1.0x
ROE 12.9%
P/B 5.1x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Jun23
Promoters
Created with Highcharts 8.2.2Jun23
Others
Created with Highcharts 8.2.2Jun23
Increase    Decrease    No change
Company Profile Detailed
Syncom Formulations (India) Ltd was originally incorporated as Syncom Formulations (India) Private Limited in the state of Maharashtra on June 21, 1988 under the Companies Act, 1956. Further the status of company was changed to public limited company and thereby name of company changed to Syncom Formulations (India) Limited and a fresh certificate of change of name obtained on July 9, 1992.
Belongs to (4 Indices)
Investors (3)
kedarmal...
vijay.ba...
payal.ba...
Followers (1)
kamleshr...